EPOCH is an intensive chemotherapy regimen used to treat aggressive non-Hodgkin lymphoma. It is often combined with the monoclonal antibody rituximab, in which case it is called R-EPOCH or EPOCH-R. Its component drugs are etoposide, a topoisomerase inhibitor; prednisolone, a corticosteroid; Oncovin, also known as vincristine, which prevents microtubule formation and mitosis; cyclophosphamide, an alkylating agent; and hydroxydaunorubicin, also known as doxorubicin, an anthracycline antibiotic that intercalates DNA.
Facts
Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundationhttps://en.wikipedia.org/wiki/EPOCH_(chemotherapy), lead sectionQuote, https://en.wikipedia.org/wiki/EPOCH_(chemotherapy), lead section
EPOCH is an intensive chemotherapy regimen intended for treatment of aggressive non-Hodgkin lymphoma.
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.